Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity

References

• Christofk HR Vander Heiden MG Wu N Pyruvate kinase M2 is a phosphotyrosine-binding protein Nature 2008 452 181 186 18337815
   PubMed Web of Science ®Google Scholar
• Chaneton B Gottlieb E Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer Trends Biochem Sci 2012 37 309 316 22626471
   PubMed Web of Science ®Google Scholar
• Christofk HR Vander Heiden MG Harris MH The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 2008 452 230 233 18337823
   PubMed Web of Science ®Google Scholar
• Altenberg B Greulich KO Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes Genomics 2004 84 1014 1020 15533718
   PubMed Web of Science ®Google Scholar
• Warburg O On the origin of cancer cells Science 1956 123 309 314 13298683
   PubMed Web of Science ®Google Scholar
• Hsu PP Sabatini DM Cancer cell metabolism: Warburg and beyond Cell 2008 134 703 707 18775299
   PubMed Web of Science ®Google Scholar
• Tamada M Suematsu M Saya H Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells Clin Cancer Res 2012 18 5554 5561 23071357
   PubMed Web of Science ®Google Scholar
• Ye J Mancuso A Tong X Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation Proc Natl Acad Sci 2012 109 6904 6909 22509023
   PubMed Web of Science ®Google Scholar
• Lv L Li D Zhao D Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth Mol Cell 2011 42 719 730 21700219
   PubMed Web of Science ®Google Scholar
• Dombrauckas JD Santarsiero BD Mesecar AD Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis Biochemistry 2005 44 9417 9429 15996096
   PubMed Web of Science ®Google Scholar
• Takenaka M Noguchi T Sadahiro S Isolation and characterization of the human pyruvate kinase M gene Eur J Biochem 1991 198 101 106 2040271
   PubMedGoogle Scholar
• Cheong H Lu C Lindsten T Therapeutic targets in cancer cell metabolism and autophagy Nat Biotech 2012 30 1 8
   Web of Science ®Google Scholar
• Yamada K Noguchi T Regulation of pyruvate kinase M gene expression Biochem Biophys Res Commun 1999 256 257 262 10079172
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ Sayed N Ditsworth D Brick by brick: metabolism and tumor cell growth Curr Opin Genet Dev 2008 18 54 61 18387799
   PubMed Web of Science ®Google Scholar
• Anastasiou D Yu Y Israelsen WJ Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis Nat Chem Biol 2012 8 839 847 22922757
   PubMed Web of Science ®Google Scholar
• Boxer MB Jiang JK Vander Heiden MG Evaluation of substituted N,N’-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase J Med Chem 2010 53 1048 1055 20017496
   PubMed Web of Science ®Google Scholar
• Jiang JK Boxer MB Vander Heiden MG Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase Bioorg Med Chem Lett 2010 20 3387 3393 20451379
   PubMed Web of Science ®Google Scholar
• Walsh MJ Brimacombe KR Veith H 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase Bioorg Med Chem Lett 2011 21 6322 6327 21958545
   PubMed Web of Science ®Google Scholar
• Xu Y Liu XH Saunders M Discovery of 3-(trifluoromethyl)-1-H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2) Bioorg Med Chem Lett 2014 24 515 519 24374270
   PubMed Web of Science ®Google Scholar
• Guo C Linton A Jalaie M Discovery of 2-((1H-benzo[d] imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators Bioorg Med Chem Lett 2013 23 3358 3363 23622982
   PubMed Web of Science ®Google Scholar
• Chen ZJ Jiang QL He G Multicomplex-Based Pharmacophore and QSAR of Aryl-Sulfamides as Pyruvate Kinase M2 Activators Acta Phys Chim Sin 2013 29 1793 1803
   Web of Science ®Google Scholar
• He G Qiu M Li R Multicomplex-based pharmacophore-guided 3D-QSAR studies of N-substituted 2′-(aminoaryl)benzothiazoles as Aurora-A inhibitors Chem Biol Drug Des 2012 79 960 971 22381081
   PubMed Web of Science ®Google Scholar
• Ouyang L He G Huang W Combined Structure-Based Pharmacophore and 3D-QSAR Studies on Phenylalanine Series Compounds as TPH1 Inhibitors Int J Mol Sci 2012 13 5348 5363 22754301
   PubMed Web of Science ®Google Scholar
• Li B Zhou R He G Molecular Docking, QSAR and Molecular Dynamics Simulation on Spiro-oxindoles as MDM2 Inhibitors Acta Chim Sin 2013 71 1396 1403
   Web of Science ®Google Scholar
• Wu F Xu T He G Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking Int J Mol Sci 2012 13 15668 15678 23443087
   PubMed Web of Science ®Google Scholar
• Peng F Peng A Luo Y Combined structure-based pharmacophore, virtual screening, and 3D-QSAR studies of structural diverse dehydrosqualene synthase inhibitors Med Chem Res 2013 22 4858 4866
   Web of Science ®Google Scholar
• Liu C He G Jiang Q Novel Hybrid Virtual Screening Protocol Based on Molecular Docking and Structure-Based Pharmacophore for Discovery of Methionyl-tRNA Synthetase Inhibitors as Antibacterial Agents Int J Mol Sci 2013 14 14225 14239 23839093
   PubMed Web of Science ®Google Scholar
• Ouyang L Huang Y Zhao Y Preparation, antibacterial evaluation and preliminary structure-activity relationship (SAR) study of benzothiazol- and benzoxazol-2-amine derivatives Bioorg Med Chem Lett 2012 22 3044 3049 22494615
   PubMed Web of Science ®Google Scholar
• Zhong H Huang W He G Molecular dynamics simulation of tryptophan hydroxylase-1: binding modes and free energy analysis to phenylalanine derivative inhibitors Int J Mol Sci 2013 14 9947 9962 23665899
   PubMed Web of Science ®Google Scholar
• Berman HM Westbrook J Feng Z The protein data bank Nucl Acid Res 2000 28 235 242
   PubMed Web of Science ®Google Scholar
• Zou J Xie HZ Yang SY Towards more accurate pharmacophore modeling: multicomplex-based comprehensive pharmacophore map and most frequent-feature pharmacophore model of CDK2 J Mol Graph Model 2008 27 430 438 18786843
   PubMed Web of Science ®Google Scholar
• Discovery Studio, version 35 Accelrys Inc San Diego, CA, USA 2012
   Google Scholar
• Irwin JJ Sterling T Mysinger MM ZINC: A Free Tool to Discover Chemistry for Biology J Chem Inf Model 2012 52 1757 1768 22587354
   PubMed Web of Science ®Google Scholar
• Irwin JJ Shoichet BK ZINC-a free database of commercially available compounds for virtual screening J Chem Inf Model 2005 45 177 182 15667143
   PubMed Web of Science ®Google Scholar
• Xiang ML Lei K Fan WJ In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features Drug Des Devel Ther 2013 7 789 839
   Web of Science ®Google Scholar
• Alam S Khan F QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα Drug Des Devel Ther 2014 8 183 195
   PubMed Web of Science ®Google Scholar
• Yadav DK Meena A Srivastava A Development of QSAR model for immunomodulatory activity of natural coumarinolignoids Drug Des Devel Ther 2010 4 173 186
   PubMed Web of Science ®Google Scholar
• Laskowski RA Swindells MB LigPlot+: multiple ligand-protein interaction diagrams for drug discovery J Chem Inf Model 2011 51 2778 2786 21919503
   PubMed Web of Science ®Google Scholar
• Luo M Wang XS Roth BL Golbraikh A Tropsha A Application of Quantitative Structure–Activity Relationship Models of 5-HT1A Receptor Binding to Virtual Screening Identifies Novel and Potent 5-HT1A Ligands J Chem Inf Model 2014 54 634 647 24410373
   PubMed Web of Science ®Google Scholar
• Enslein K Blake BW Borgstedt HH Prediction of probability of carcinogenicity for a set of ongoing NTP bioassays Mutagenesis 1990 5 305 306 2398815
   PubMed Web of Science ®Google Scholar
• Chaudhaery SS Roy KK Saxena AK Consensus Superiority of the Pharmacophore-Based Alignment, Over Maximum Common Substructure (MCS): 3D-QSAR Studies on Carbamates as Acetylcholinesterase Inhibitors J Chem Inf Model 2009 49 1590 1601 19441865
   PubMed Web of Science ®Google Scholar
• Roth BL Baner K Westkaemper R Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist Proc Natl Acad Sci U S A 2002 99 11934 11939 12192085
   PubMed Web of Science ®Google Scholar